Tipe Koleksi	No. Panggil	Judul	Pengarang	Subjek	Penerbit	Tahun
Prosiding	P 362.1 WOR w	Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems:             1. Responsiveness measures: consumer assessment of health plans study (CAHPS TM);  2. The use of cognitive testing to develop and evaluate CAHPS TM 1.0 core survey items;  3. Psychometric properties of the CAHPS TM 1.0 survey measures;  4. WHO strategy on measuring responsiveness;  5. Measuring responsiveness: results of a key informants survey in 35 countries;  6. WHO survey on health and health system responsiveness: questionnaire sections - draft;  7. Health system responsiveness survey : draft questionnaire - responsiveness section only;  8. Surveying health system preferences: Measuring preferences on health system performance assessment;  9. Overall goal attainment: Human development index: methodology and mmeasurement;  10. Good and bad growth: the human development reports;  11. Overall performance concepts: The comparative efficiency of national health systems in producing health: an analysis of 191 countries;  12. Frontier production functions and technical efficiency measures;  13. The estimation of technical efficiency;  14. Production frontiers and panel data;  15. Overall performance measures: The efficiency of government expenditure: experiences from Africa;  16. Measuring health production performance in the OECD;  17. What do the human development indices reveal?;  18. Exercise on measuring preferences: Health financing: Uncertainty and the welfare economics of medical care;  19. Incentives and provider payment methods;  20. Health insurance schemes for people outside formal sector employment;  21. New Zealand's health reforms: a clash of culture;  22. Improving allocative efficiency of health interventions: searching  for policy tools;  23. Public and private roles in health: theory and financing patterns;  24. Some interim results from a controlled trial of cost sharing in health insurance;  25. Primary care reform: a country comparison of 'budget holding';  26. Provision: Design, content and financing of an essential national package of health services;  27. The history and pronciples of managed competition;  28. Limits to rationality: economics, economists and priority setting;  29. Sub-National application of health systems performance framework: Measuring overall health system performance for 191 countries;  30. 	WHO:  1. Morris Weinberger;  2. Lauren D. Harris-Kojetin (et al);  3. Ron D. Hays  (et al);  4. Charles darby  (et al);  5. Amala de Silva;  Nicole Valentine;  6. WHO;  7. WHO; 8. WHO; Emmanuela Gakidou;  Christopher JL Murray;  Julio Frenk;  9. Sudhir Anand;  Amartya K. Sen;  10. Martin Ravallion;  11. David B Evans  (et al);  12. K.P. Kalirajan;  R.T. Shand;  13. (?);  14. Peter Schmidt;  Robin C. Sickles;  15. Sanjeev Gupta;  Heiko Honjo; Marijn Verhoeven;  16. Jaume puig-Junoy;  17. (?);  18. Kenneth J. Arrow;  19. Howard Barnum;  Joseph Kutzin;  Helen Saxenian;  20. Sara Bennett;  Andrew Creese;  Roeland Monasch;  21. Andrew Hornblow;  22. (?);  23. Philip Musgrove;  24. Joseph P. Newhouse;  25. Paula Wilton;  Richard D. Smith;  26. L. Bobadilla  (et al);  27. Alain C. Enthoven;  28. Ray Robinson;  29. Ajay ;Tandon  (et al);  30. 	Health Policy-Workshop; Health Expenditure-Proceedings; Cost Benifit Analysis-Proceedings; Cost Effectiveness-Proceedings	Geneva: WHO, 2000	
Prosiding	P 362.1 WOR w	Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems.                                       (Daftar isi:  1. Foundations of cost-effectiveness analysis  for health and medical practices, Milton C. Weinsrein;  StasonWilliam B.;   2. Cost-effectiveness analysis: an introductory guide for clinicians, Marcones, George A;   3. Developmentof WHO guidelines on generalized cost-effectiveness analysis, Murray, Christopher J.L;   (et al);   4.   Cost analysis in primary health care: a training manual for programme managers, Andrew Creese;   5. Public hospitals in developing countries: resource use, cost, financing, Howard Barnum;   6. Methods for the economic evaluation of health care programmes, Michael F. Drummond;   7. National price levels and the prices of tradables and nontradables, Irving B. Kravis;   8. For here or to go ? Purchasing power parity and the big mac, Michael R. Pakko;   9. Cost-analysis: issues and methodologies, Anandarup Ray;   10. THe Penn World Table (PWT) estimates of purchasing power parities and consumption, invesment, and governt price parities for non-benchmark countries (with special reference to PWT 5.6), Alan Heston;   11. The real and nominal? making inflationary adjusments to cost and other economic data, Lilani Kumaranayake;   12. Discounting human lives, Maureen L Cropper;   13. Methods for the economic evaluation of health care programmes, Michael F. Drummond;   14. Time preference, J. Lipscomp;   15. Time preference in medical making and cost-effectiveness analysis , Donald A Redelmier;   15. Discounting costs and effects: a reconsideration, Ben A. Van Hout;   16. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, FRank A. Sloan;   17. Standardizing methodologies for economic evaluation in health care: practice, problems, and potential, Michael Drummond;   18. How much does excess inpatient capacity really cost ?, Parves R. Sopariwala;   19. Applying ABC to healthcare: as rising costs impact managed care, a successful manufacturing costing method is being applied to help managers make decisions on capitation contract bidding, cost containment, and organizational structure, Twothy D. West;   20.. IMCI multi-country evaluation form 5 A: health facility costs questionnaire;   21. The usefulness of rations for allocation decisions: the case of stroke, A. Ament;   22. A review of the use of health status measures in economic evaluation, J Brazier;   23. Preference-based measures in economic evaluation in health care, Peter J. Neumann;   24. Multi-aatribute preference functions: health utilities index, George W. Torrance;   25. Utilities and quality-adjusted life years, George W. Torrance;   26. Disability-adjusted life years: a critical review, Sudhir anand;   27. Understanding DALYs, Christopher J.L. Murray;   28. QALYs, HYEs and individualpreferences - a graphical illustration, Magnus Johannesson;   29. What randomized trials and systematic reviews can offer decision makers, Douglas G. Altman;   30. Evaluation of health interventions at area and organisation level, Obioha C Ukoumunne;   31. Interpreting the evidence: choosing between randomised and non-randomised studis, Martin McKee;   32. An evidence based approach to individualising treatment, Paul P. Glasziou;   33. Efficacy and effectiveness issues in the NIDA cooperative agreement: interventions for out-of-teatment drug-users;   34. The practice of antenatal care: comparing four study sites in different parts of the world participating in the WHO antenatal care rondomized controlled trial, Gilda Piaggio;   35. Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease, Thommas A. Pearson)	WHO	Health Policy-Workshop; Health Expendditure-Proceedings; Cost Benefit Analysis-Proceedings; Cost Effectiveness-Proceedings	Geneva: WHO, 2000